{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:45:57Z","timestamp":1787168757073,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.vaccine.2014.01.066","type":"journal-article","created":{"date-parts":[[2014,2,7]],"date-time":"2014-02-07T17:45:31Z","timestamp":1391795131000},"page":"1890-1895","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Seroprevalence of rubella antibodies in The Netherlands after 32 years of high vaccination coverage"],"prefix":"10.1016","volume":"32","author":[{"given":"Gaby","family":"Smits","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbeth","family":"Mollema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hahn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester","family":"de Melker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Tcherniaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"van der Klis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Berbers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.vaccine.2014.01.066_bib0005","first-page":"7","article-title":"Congenital defects associated with maternal rubella","volume":"14","author":"Gregg","year":"1947","journal-title":"Aust Hosp"},{"key":"10.1016\/j.vaccine.2014.01.066_bib0010","series-title":"Advies inzake Bof-\/Rubella-vaccinatie","author":"Gezondheidsraad","year":"1984"},{"issue":"24","key":"10.1016\/j.vaccine.2014.01.066_bib0015","first-page":"1150","article-title":"Vaccination against mumps and rubella, advice of the Health Council","volume":"128","author":"van der Veen","year":"1984","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"3","key":"10.1016\/j.vaccine.2014.01.066_bib0020","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1017\/S0950268898001472","article-title":"A model-based evaluation of the national immunization programme against rubella infection and congenital rubella syndrome in The Netherlands","volume":"121","author":"van der Heijden","year":"1998","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2014.01.066_bib0025","series-title":"RIVM Rapport 150202001\/2013","article-title":"Immunization coverage National Immunization Programme in The Netherlands","author":"van Lier","year":"2013"},{"issue":"8624","key":"10.1016\/j.vaccine.2014.01.066_bib0030","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S0140-6736(88)90920-8","article-title":"Measles, mumps, and rubella vaccine: what coverage to block transmission?","volume":"2","author":"Nokes","year":"1988","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.vaccine.2014.01.066_bib0035","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/INF.0b013e3181a3e2d5","article-title":"Rubella outbreak in The Netherlands, 2004\u20132005: high burden of congenital infection and spread to Canada","volume":"28","author":"Hahne","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2014.01.066_bib0040","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/eurpub\/ckr081","article-title":"Measuring vaccination coverage in a hard to reach minority","volume":"22","author":"Ruijs","year":"2012","journal-title":"Eur J Public Health"},{"issue":"3","key":"10.1016\/j.vaccine.2014.01.066_bib0045","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1017\/S0950268898001587","article-title":"Immunosurveillance and the evaluation of national immunization programmes: a population-based approach","volume":"121","author":"De Melker","year":"1998","journal-title":"Epidemiol Infect"},{"issue":"7","key":"10.1016\/j.vaccine.2014.01.066_bib0050","first-page":"301","article-title":"Second national serum bank for population-based seroprevalence studies in The Netherlands","volume":"67","author":"van der Klis","year":"2009","journal-title":"Neth J Med"},{"issue":"49","key":"10.1016\/j.vaccine.2014.01.066_bib0055","doi-asserted-by":"crossref","first-page":"7803","DOI":"10.1016\/j.vaccine.2010.09.036","article-title":"High tetanus antitoxin antibody concentrations in The Netherlands: a seroepidemiological study","volume":"28","author":"Steens","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2014.01.066_bib0060","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1128\/CVI.05537-11","article-title":"Development of a bead-based multiplex immunoassay for the simultaneously quantitative detection of IgG serum antibodies against measles, mumps, rubella and varicella zoster","volume":"19","author":"Smits","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2014.01.066_bib0065","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1017\/S0950268899004173","article-title":"The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubella","volume":"125","author":"Andrews","year":"2000","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2014.01.066_bib0070","series-title":"R: A language and environment for statistical computing","author":"Team, T.R.D.C.","year":"2011"},{"key":"10.1016\/j.vaccine.2014.01.066_bib0075","series-title":"Mathematical statistics: basic ideas and selected topics","first-page":"101","article-title":"Basic heuristics of estimation","author":"Bickel","year":"2001"},{"issue":"2","key":"10.1016\/j.vaccine.2014.01.066_bib0080","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1017\/S0950268899002939","article-title":"Prevalence of antibodies against rubella virus in The Netherlands 9 years after changing from selective to mass vaccination","volume":"123","author":"de Haas","year":"1999","journal-title":"Epidemiol Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2014.01.066_bib0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0264-410X(94)90009-4","article-title":"Long-term follow-up study of rubella antibodies in naturally immune and vaccinated young adults","volume":"12","author":"Christenson","year":"1994","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2014.01.066_bib0090","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM199411243312101","article-title":"The elimination of indigenous measles: mumps, and rubella from Finland by a 12-year, two-dose vaccination program","volume":"331","author":"Peltola","year":"1994","journal-title":"N Engl J Med"},{"issue":"37\u201338","key":"10.1016\/j.vaccine.2014.01.066_bib0095","doi-asserted-by":"crossref","first-page":"6672","DOI":"10.1016\/j.vaccine.2007.07.008","article-title":"Long-term persistence of antibodies after one or two doses of MMR-vaccine","volume":"25","author":"Vandermeulen","year":"2007","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2014.01.066_bib0100","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1093\/clinids\/7.Supplement_1.S80","article-title":"Persistence of vaccine-induced immune responses to rubella: comparison with natural infection","volume":"7","author":"Horstmann","year":"1985","journal-title":"Rev Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2014.01.066_bib0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1017\/S0950268803001584","article-title":"Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study","volume":"132","author":"Mossong","year":"2004","journal-title":"Epidemiol Infect"},{"issue":"19","key":"10.1016\/j.vaccine.2014.01.066_bib0110","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1056\/NEJMoa066092","article-title":"Duration of humoral immunity to common viral and vaccine antigens","volume":"357","author":"Amanna","year":"2007","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.vaccine.2014.01.066_bib0115","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/infdis\/jis568","article-title":"Waning antibody levels and avidity: implications for MMR vaccine-induced protection","volume":"206","author":"Kontio","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.01.066_bib0140","unstructured":"http:\/\/www.rivm.nl\/Documenten_en_publicaties\/Algemeen_Actueel\/Nieuwsberichten\/2013\/Start_extra_vaccinatie_tegen_mazelen Accessed again on 12-02-2014."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14001182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14001182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T15:59:46Z","timestamp":1538841586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14001182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":24,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0264410X14001182"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.01.066","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seroprevalence of rubella antibodies in The Netherlands after 32 years of high vaccination coverage","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.01.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}